ReferIndia News Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar

ReferIndia News

✅ Secure, cloud-based clinic management.

Digital prescriptions, appointments, billing & records — all in one.

Learn More
News Image

Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar

Published on: May 1, 2026, 3:16 p.m. | Source: NDTV Profit

Available in 100 mg and 400 mg formulations, the originator product Avastin is marketed by Roche/Genentech, filing added.

Checkout more news
Ad Banner

Looking for a side income?

Work on your own terms — become a freelancer with us! Choose projects you love, set your own schedule, and start earning today. No fixed hours, no limits — just flexibility and freedom.

Know more
ReferIndia News contact